Robert Iannone
Chief Tech/Sci/R&D Officer at JAZZ PHARMACEUTICALS PLC
Net worth: 7 M $ as of 2024-03-30
Profile
Dr. Robert Iannone, MD, is an Independent Director at iTeos Therapeutics, Inc., an Independent Director at Jounce Therapeutics, Inc. and a Chief Medical Officer, EVP-Research & Development at Jazz Pharmaceuticals Plc. He is on the Board of Directors at iTeos Therapeutics, Inc. and Jounce Therapeutics, Inc. Dr. Iannone was previously employed as a Chief Medical Officer, Head-Research & Development by Immunomedics, Inc., a SVP, Head-Immuno-Oncology & Global Medicines by AstraZeneca Plc, an Executive Director & Head-Oncology by Merck & Co., Inc., and an Adjunct Assistant Professor by University of Pennsylvania Medical Center. He received his undergraduate degree from The Catholic University of America, a graduate degree from the University of Pennsylvania Medical Center and a doctorate degree from Yale School of Medicine.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-04 | 62,226 ( 0.10% ) | 7 M $ | 2024-03-30 | |
ITEOS THERAPEUTICS, INC.
-.--% | 2023-06-12 | 0 ( -.--% ) | - $ | 2024-03-30 |
Robert Iannone active positions
Companies | Position | Start |
---|---|---|
JAZZ PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 2019-05-28 |
ITEOS THERAPEUTICS, INC. | Director/Board Member | 2021-05-02 |
AUTOLUS THERAPEUTICS PLC | Director/Board Member | 2023-06-19 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | 2019-04-30 |
Former positions of Robert Iannone
Companies | Position | End |
---|---|---|
JOUNCE THERAPEUTICS, INC. | Director/Board Member | 2023-05-02 |
IMMUNOMEDICS, INC. | Chief Tech/Sci/R&D Officer | 2019-05-27 |
ASTRAZENECA PLC | Corporate Officer/Principal | 2018-03-31 |
MERCK & CO., INC. | Director/Board Member | 2014-06-30 |
University of Pennsylvania Medical Center | Corporate Officer/Principal | 2011-12-31 |
Training of Robert Iannone
The Catholic University of America | Undergraduate Degree |
Yale University | Doctorate Degree |
University of Pennsylvania Medical Center | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
MERCK & CO., INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
AUTOLUS THERAPEUTICS PLC | Health Technology |
ITEOS THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Robert Iannone